Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
Lauren Buchanan
Advertisement
Articles by Lauren Buchanan
The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
The Pharmacist’s Expertise in Managing Pneumococcal Diseases, Vaccines
2
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
3
What TrumpRx Means for Independent Pharmacies and Their Patients
4
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
5
